Text Messaging (TM) + No Patient Navigation for Coronavirus

University of Utah, Salt Lake City, UT
Coronavirus+19 More ConditionsConversational Agent (CA) - Behavioral
All Sexes

Study Summary

This trial will increase access to COVID-19 testing and vaccination among underserved populations in Utah using PHM interventions and available technology.

Eligible Conditions
  • Coronavirus
  • COVID-19, Thalidomide Syndrome
  • Coronavirus Disease 2019 (COVID-19)
  • COVID-19; Cardiovascular Disease
  • COVID-19
  • Long-haul COVID-19
  • Long COVID
  • COVID-19 (coronavirus disease 2019)
  • Positive SARS-CoV-2 PCR Test
  • Mild-to-Moderate COVID-19

Treatment Effectiveness

Study Objectives

1 Primary · 5 Secondary · Reporting Duration: Year 1

Year 1
Reach-Accept Testing
Reach-Engage Testing
Reach-Engage Vaccine

Trial Safety

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

4 Treatment Groups

Text Messaging (TM) + No Patient Navigation
1 of 4
Text Message (TM) + Request (RPN)
1 of 4
Conversational Agent (CA)+ No Patient Navigation
1 of 4
Conversational Agent (CA) + Request PN (RPN)
1 of 4

Active Control

112479 Total Participants · 4 Treatment Groups

Primary Treatment: Text Messaging (TM) + No Patient Navigation · No Placebo Group · N/A

Text Messaging (TM) + No Patient Navigation
ActiveComparator Group · 1 Intervention: Text-Messaging (TM) · Intervention Types: Behavioral
Text Message (TM) + Request (RPN)ActiveComparator Group · 2 Interventions: Patient Navigation (PN), Text-Messaging (TM) · Intervention Types: Behavioral, Behavioral
Conversational Agent (CA)+ No Patient Navigation
ActiveComparator Group · 1 Intervention: Conversational Agent (CA) · Intervention Types: Behavioral
Conversational Agent (CA) + Request PN (RPN)ActiveComparator Group · 2 Interventions: Conversational Agent (CA), Patient Navigation (PN) · Intervention Types: Behavioral, Behavioral

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: year 1

Who is running the clinical trial?

Association for Utah Community HealthOTHER
3 Previous Clinical Trials
332,805 Total Patients Enrolled
National Institute on Minority Health and Health Disparities (NIMHD)NIH
318 Previous Clinical Trials
1,212,607 Total Patients Enrolled
National Institutes of Health (NIH)NIH
2,552 Previous Clinical Trials
24,500,113 Total Patients Enrolled
University of UtahLead Sponsor
1,022 Previous Clinical Trials
1,663,896 Total Patients Enrolled
Utah Department of HealthOTHER
6 Previous Clinical Trials
508,462 Total Patients Enrolled
Guilherme Del Fiol, MD PhDPrincipal InvestigatorUniversity of Utah
1 Previous Clinical Trials
112,479 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 4 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Frequently Asked Questions

Are there any remaining spots available for the trial?

"This clinical trial is currently seeking participants, with records of its posting and last update dates being available on clinicaltrials.gov. The study was originally posted to the site on 15th January 2023 and the most recent updates occurred 8th May 2023." - Anonymous Online Contributor

Unverified Answer

Could you provide an estimation of the number of participants who have agreed to join this experiment?

"Affirmative, data posted to clinicaltrials.gov indicates that the trial is actively seeking participants and was initially posted on 15 January 2023 with a subsequent update dated 8 May 2023. The study necessitates 112479 individuals at one site for enrollment." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.